A relationship between insulin resistance and NAFLD has been previously described and suggests that therapies targeting an increase in insulin sensitivity may be beneficial for the prevention of the development of NAFLD [62]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.